Sirolimus DEB in Coronary Bifurcation Lesions
Clinical trial NCT04896177 · RECRUITING
Trial details
- NCT number
- NCT04896177
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-18
- Primary completion
- 2025-09-18
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.